A lot can happen in a month, here’s some of the latest regulatory developments in the industries we serve with some narrative.

Animal Health – Australia (APVMA)

Your comments on the proposed update to the APVMA GMP audit procedure

  • Some important issues to address in this proposal, click here
  • This is essential reading if you participate in APVMA audits
  • Submissions close 22/8/2024

New Minister for Agriculture, Fisheries and Forestry

  • The Hon. Julie Collins replaces The Hon. Murray Watt as of 29/7/2024
  • a former Shadow Minister for Agriculture when Labor were in opposition, so she is across some of the issues affecting the industry;
  • mixed opinions on the appointment have been shared from both sides of politics

New APVMA leadership now in place

  • New APVMA CEO Mr Scott Hansen started with the APVMA on 24/7/2024
  • Dr Catherine Ainsworth has commenced her appointment to the role of APVMA Board Chair since mid-July.
  • Looking forward to the promised strong leadership and governance arising from the various reviews

Keep on top of manufacture sites in your APVMA product files

  • Clients are reporting letters from the APVMA requesting updates to manufacture sites for products as the sites in the product register do not have a current APVMA manufacturing licence
  • Main cause is manufacturers, particularly laboratories may have changed address over time
  • Australia does not have a regular review period for registrations, these details can missed
  • The update process is quite straight forward, Item 13A/ $175 (per product)/ approx. 1 month turnaround
  • Pia Pharma analytical service and regulatory clients, contact us for a special rate to update your records

Keep an eye on your MLS audit close out timeframe

  • APVMA advise there will be a temporary extension of audit timeframes
  • Read more here
  • VMDA members contact us if you have issues

Clarification of recall process for Agvet chemicals

Watch this space – APVMA GMP code review underway

  • The APVMA are intent on contemporising the Australian Code of Good Manufacture Practice for Veterinary Chemical Products;
  • Review underway using several ‘undisclosed’ reviewers;
  • First proposed amendments through the APVMA Industry Liaison Committee sometime in September or October 2024;
  • More to say about this when we have a few more details.

Dr Tanita Wierenga moves to Manufacturers’ Licensing Scheme (MLS)

  • Tanita has moved out of APVMA Chemistry
  • now Assistant Director of MLS as the APVMA backfill after Sam Becketts departure;
  • No news on replacement in Chemistry, expect delays with reviews
  • Keep an eye on the technical Chemistry questions, always a challenge with inexperienced evaluators;
  • Useful link to the APVMA Risk Assessment Manual for Chemistry and Manufacture
  • Call us if you need assistance

 

Pharmaceuticals – Australia (TGA)

Nitrosamines in Medicines – Update to Acceptable Intake

  • The TGA has published updated acceptable intake (AI) information for nitrosamine impurities in medicines consistent with recent EMA information.
  • Sponsors and manufacturers are expected to be familiar with the current acceptable intakes (AI) for nitrosamine impurities in medicines;
  • Pia Pharma has experience with trace level nitrosamines in pharmaceutical products

 

Animal Health – New Zealand (ACVM)

ACVM Annual Workshop (31/7/2024)

  • Good attendance at this seminar
  • Copy of the ACVM Workshop Presentations here
  • Best presentation goes to ‘How to submit a great application’ – I’ll be rereading that!

ACVM Workload update July

  • 38 applications in the que, 104 applications in appraisal
  • Higher than norma influx of applications
  • ACVM are not meeting their statutory assessment timeframes